Weight, Anthropometric and Metabolic Changes After Discontinuing Antiretroviral Therapy Containing Tenofovir Alafenamide in People With HIV.

MLA

Damas, José, et al. “Weight, Anthropometric and Metabolic Changes After Discontinuing Antiretroviral Therapy Containing Tenofovir Alafenamide in People With HIV.” Clinical Infectious Diseases, vol. 79, no. 4, Oct. 2024, pp. 990–98. EBSCOhost, https://doi.org/10.1093/cid/ciae189.

APA

Damas, J., Munting, A., Fellay, J., Haerry, D., Marzolini, C., Tarr, P. E., Steffen, A., Braun, D. L., Stoeckle, M., Bernasconi, E., Tshikung, O. N., Fux, C. A., Darling, K. E. A., Béguelin, C., Wandeler, G., Cavassini, M., Surial, B., & SHCS), the Swiss HIV Cohort Study. (2024). Weight, Anthropometric and Metabolic Changes After Discontinuing Antiretroviral Therapy Containing Tenofovir Alafenamide in People With HIV. Clinical Infectious Diseases, 79(4), 990–998. https://doi.org/10.1093/cid/ciae189

Chicago

Damas, José, Aline Munting, Jacques Fellay, David Haerry, Catia Marzolini, Philip E Tarr, Ana Steffen, et al. 2024. “Weight, Anthropometric and Metabolic Changes After Discontinuing Antiretroviral Therapy Containing Tenofovir Alafenamide in People With HIV.” Clinical Infectious Diseases 79 (4): 990–98. doi:10.1093/cid/ciae189.